HTFL

Heartflow Inc

48.29

Oct 16 • 3:59 PM ET -2.61 (-5.14%)

48.00

Aftermarket • 7:39 PM ET -0.29 (-0.60%)

Healthcare Health Information Services USA Mid NASD

Peers: DOCS TDOC GDRX HQY PHR EVH AMWL DH LFMD HIMS

| Held by: VTI IWM VB VBR VXF IWO VTWO SCHA VHT FBCG

Scroll to Statements

Index	RUT
Market Cap	4.20B
Enterprise Value	4.06B
Income	-118.37M
Sales	212.07M
Book/sh	3.23
Cash/sh	1.87
Dividend Est.	-
Dividend TTM	-
Dividend Ex-Date	-
Dividend Gr. 3/5Y	- -
Payout	-
Employees	843
IPO	Aug 08, 2025

P/E	-
Forward P/E	-
PEG	-
P/S	19.80
P/B	14.97
P/C	25.83
P/FCF	-
EV/EBITDA	-
EV/Sales	19.16
Quick Ratio	4.87
Current Ratio	4.87
Debt/Eq	0.10
LT Debt/Eq	0.07
Option/Short	Yes / Yes

EPS (ttm)	-1.40
EPS next Y	-0.26
EPS next Q	-0.10
EPS this Y	74.39%
EPS next Y	38.02%
EPS next 5Y	-
EPS past 3/5Y	5.20% -
Sales past 3/5Y	42.10% -
EPS Y/Y TTM	-
Sales Y/Y TTM	-
EPS Q/Q	-65.19%
Sales Q/Q	47.57%
Earnings	Aug 13 AMC
EPS/Sales Surpr.	47.64% 13.15%

Insider Own	25.44%
Insider Trans	-9.89%
Inst Own	82.84%
Inst Trans	35.61%
ROA	-46.99%
ROE	-154.23%
ROIC	-39.45%
Gross Margin	80.08%
Oper. Margin	-34.31%
Profit Margin	-55.82%
SMA20	-2.70%
SMA50	3.05%
SMA200	46.94%
Trades

Shs Outstand	86.72M
Shs Float	64.87M
Short Float	10.50%
Short Ratio	3.77
Short Interest	6.81M
52W High	54.32 -11.10%
52W Low	20.13 139.89%
Volatility	5.65% 5.55%
ATR (14)	2.71
RSI (14)	48.76
Beta	2.73
Rel Volume	0.57
Avg Volume	1.81M
Volume	1,023,936

Perf Week	-2.92%
Perf Month	-2.58%
Perf Quarter	96.62%
Perf Half Y	54.08%
Perf YTD	65.66%
Perf Year	44.28%
Perf 3Y	-
Perf 5Y	-
Perf 10Y	-
Recom	1.50
Target Price	47.22
Prev Close	50.90
Price	48.29
Change %	-5.14%

Date	Action	Analyst	Rating Change	Price Target Change
Sep-09-26	Resumed	UBS	Neutral	$55
Jul-31-26	Initiated	Robert W. Baird	Outperform	$34
May-04-26	Initiated	William Blair	Outperform
Jan-28-26	Initiated	Wells Fargo	Overweight	$38
Sep-02-25	Initiated	Stifel	Buy	$35
Sep-02-25	Initiated	Piper Sandler	Overweight	$38
Sep-02-25	Initiated	Morgan Stanley	Equal-Weight	$35
Sep-02-25	Initiated	JP Morgan	Overweight	$36
Sep-02-25	Initiated	Canaccord Genuity	Buy	$35

Aug-28-26 02:48AM	Late Breaking Data from Independent Government-Funded Trial at ESC Shows Heartflow FFRCT Analysis Reduces Unnecessary Invasive Heart Procedures by Nearly Half (GlobeNewswire)
Aug-27-26 04:01PM	Heartflow to Participate in the Wells Fargo 21st Annual Healthcare Conference (GlobeNewswire)
Aug-14-26 10:11AM	This AI-Tied IPO Stock Just Broke Out On Its 'Outsized' Guidance Boost (Investor's Business Daily) +35.70%
08:30AM	Heartflow, Inc. Common Stock Q2 2026 Earnings Call Summary (Moby)
01:02AM	HeartFlow Inc (HTFL) (Q2 2026) Earnings Call Highlights: Revenue Surges 48% and Plaque Momentum ... (GuruFocus.com)
04:28PM	Loading…
Aug-13-26 04:28PM	HeartFlow: Q2 Earnings Snapshot (Associated Press)
04:01PM	Heartflow Reports Second Quarter 2026 Financial Results and Raises Full Year 2026 Guidance (GlobeNewswire)
Aug-12-26 09:21AM	HeartFlow Inc (HTFL) Q2 2026 Earnings Report Preview: What To Expect (GuruFocus.com)
Jul-31-26 09:46AM	Roblox downgraded, Quanta Services upgraded: Wall Street's top analyst calls (The Fly)
Jul-23-26 04:01PM	Heartflow to Report Second Quarter 2026 Financial Results on August 13, 2026 (GlobeNewswire)
Jul-21-26 08:22AM	Nvidia Returns to NZS Growth Fund (GuruFocus.com)
Jul-09-26 08:00AM	New Data at SCCT 2026 Reinforce Heartflow Plaque Analysis as the Standard for AI-Powered Coronary Artery Disease Management (GlobeNewswire) +6.00%
Jun-16-26 09:11AM	16 Million People, One Underserved Disease: The AI Imaging Push to Close the Congenital Heart Gap (PR Newswire)
May-15-26 01:02AM	HeartFlow Inc (HTFL) Q1 2026 Earnings Call Highlights: Robust Revenue Growth and Raised ... (GuruFocus.com) -12.17%
May-14-26 04:28PM	HeartFlow: Q1 Earnings Snapshot (Associated Press)
04:01PM	Loading…
04:01PM	Heartflow Reports First Quarter 2026 Financial Results and Raises Full Year 2026 Guidance (GlobeNewswire)
May-13-26 09:16AM	What To Expect From HeartFlow Inc (HTFL) Q1 2026 Earnings (GuruFocus.com) +6.05%
Apr-23-26 04:05PM	Heartflow to Report First Quarter 2026 Financial Results on May 14, 2026 (GlobeNewswire) -5.13%
Apr-13-26 08:30AM	Heartflow Files Patent Infringement Lawsuit Against Cleerly (GlobeNewswire)
Mar-27-26 09:30AM	How Decentralized AI is Unlocking Value in Cardiac Diagnostics (PR Newswire)
Mar-18-26 11:00PM	HeartFlow Inc (HTFL) Q4 2025 Earnings Call Highlights: Record Revenue Growth and Strategic ... (GuruFocus.com) +13.10%
04:22PM	HeartFlow: Q4 Earnings Snapshot (Associated Press Finance)
04:01PM	Heartflow Reports Fourth Quarter and Full Year 2025 Financial Results (GlobeNewswire)
Mar-17-26 09:18AM	Earnings To Watch: HeartFlow Inc (HTFL) Reports Q4 2025 Result (GuruFocus.com) +7.34%
Mar-16-26 08:00AM	Heartflow Builds Evidence Base Across the Heart Disease Care Continuum, From Precision Risk Stratification to CT-Guided Intervention Planning (GlobeNewswire)
Feb-25-26 01:26AM	Heartflow, Inc. (HTFL) Announces an Expansion of its GAMEFILM Registry (Insider Monkey)
Feb-18-26 04:05PM	Heartflow to Participate in the Morgan Stanley Technology, Media & Telecom Conference (GlobeNewswire) +6.33%
Feb-13-26 04:21PM	Heartflow to Report Fourth Quarter and Full Year 2025 Financial Results on March 18, 2026 (GlobeNewswire) -8.14% +7.79%
Feb-12-26 08:00AM	Heartflow Expands GAMEFILM Registry to NBA and NHL Alumni, Precisely Measuring Heart Disease Risk in Former Professional Athletes (GlobeNewswire) -16.55%
Jan-29-26 09:41AM	PayPal downgraded, UPS upgraded: Wall Streets top analyst calls (TipRanks)
09:39AM	Loading…
Jan-28-26 09:39AM	PayPal downgraded, UPS upgraded: Wall Street's top analyst calls (The Fly)
Jan-06-26 08:00AM	Heartflow Plaque Analysis Now Covered by Aetna Insurance Plans Nationwide and for the Majority of Insured Lives in the U.S. (GlobeNewswire)
Jan-05-26 04:05PM	Heartflow to Participate in the 44th Annual J.P. Morgan Healthcare Conference (GlobeNewswire)
Dec-23-25 11:53PM	Insiders Step in on These 2 Strong Buy Stocks And Analysts Are on the Same Page (TipRanks)
Dec-18-25 07:42PM	Why AI Stock HeartFlow Triumphed on Thursday (Motley Fool) +8.98% +6.49%
04:05PM	Heartflow Plaque Analysis Now Supported by Scientific Statements From American College of Cardiology and American Heart Association for Personalized Management of Patients with Suspected CAD (GlobeNewswire)
Dec-12-25 09:49AM	AI Diagnostics Hit Critical Mass as Hospitals Race to Cut Costs (PR Newswire) -6.60%
Dec-11-25 03:10AM	Heartflow FFRCT Analysis Delivers Prognostic Power and Significant Cost Savings in New Analyses of Over 90,000 Patients with Coronary Artery Disease (GlobeNewswire)
Nov-19-25 04:33PM	Heartflow to Participate in the Piper Sandler 37th Annual Healthcare Conference (GlobeNewswire)
Nov-12-25 04:22PM	HeartFlow: Q3 Earnings Snapshot (Associated Press Finance) -13.43%
04:01PM	Heartflow Reports Third Quarter 2025 Financial Results (GlobeNewswire)
Nov-09-25 01:30PM	AHA 2025: Late-Breaking Data Reinforce the Prognostic Power of AI-Driven Heartflow Plaque Analysis as the Most Clinically Validated Framework for Coronary Risk Stratification (GlobeNewswire)
Nov-04-25 07:06AM	Strong Investor Reception of IPO Boosted Heartflow (HTFL) in Q3 (Insider Monkey)
Nov-03-25 08:00AM	Heartflow to Present Late-Breaking Data Advancing AI-Driven Heartflow Plaque Analysis at AHA 2025 (GlobeNewswire) -8.38%
Oct-23-25 04:05PM	Heartflow to Report Third Quarter 2025 Financial Results on November 12, 2025 (GlobeNewswire) -5.11%
Oct-22-25 08:00AM	New Heartflow PCI Navigator to Equip Interventional Cardiologists with Pre-procedural Insights to Enable PCI Planning (GlobeNewswire) +7.27%
Sep-29-25 08:07AM	HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis (Zacks)
Sep-23-25 06:55PM	Why HeartFlow Stock Rocketed 14% Higher Today (Motley Fool) +14.13%
Sep-22-25 04:05PM	Heartflow Announces FDA 510(k) Clearance and Launch of Next Generation Heartflow Plaque Analysis Platform (GlobeNewswire)
Sep-19-25 05:28PM	HeartFlow: Q2 Earnings Snapshot (Associated Press Finance)
Sep-11-25 01:00AM	IPO Mania Is Back. Is It the Late 1990s All Over Again? (Barrons.com)
Sep-06-25 06:35AM	AI-Enabled Heart Diagnostics Put HeartFlow (HTFL) in the Spotlight (Insider Monkey)
Sep-04-25 10:20AM	Figma Stock Tumbles 20%. Why Its First Earnings Report Since IPO Was Disappointing. (Barrons.com) +8.97%
Sep-03-25 04:54PM	Figma Stock Tumbles. Why Its First Earnings Report Since IPO Was Disappointing. (Barrons.com)
04:54PM	Figma Stock Tumbles. What Disappointed in Its First Earnings Report Since Its IPO. (Barrons.com)
09:16AM	Figma's Earnings Will Be a Big Test for Software and IPOs (Barrons.com)
Sep-02-25 09:45AM	Elf Beauty downgraded, Zscaler upgraded: Wall Street's top analyst calls (The Fly)
Aug-27-25 04:24PM	Heartflow to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference (GlobeNewswire) +10.77% -7.54%
Aug-18-25 01:16PM	Gemini Files for an IPO. The Winklevoss Twins Are Behind This Crypto Exchange. (Barrons.com)
Aug-11-25 04:30PM	Heartflow, Inc. Announces Closing of Upsized Initial Public Offering and Full Exercise of the Underwriters' Option to Purchase Additional Shares (GlobeNewswire)
Aug-09-25 09:53AM	Heartflow (HTFL) Soars 66% on IPO on Strong Investor Confidence (Insider Monkey)
Aug-08-25 01:40PM	Heartflow shares surge in Nasdaq debut (Investing.com)
Jul-22-25 06:28PM	Heartflow Plaque Analysis to be Covered by UnitedHealthcare Plans Nationwide (GlobeNewswire)

HeartFlow, Inc. operates as a cardiovascular company which engages in diagnosing coronary artery diseases. The firm provides a patient-specific analysis of coronary blood flow utilizing coronary CT scans and proprietary computer algorithms based on computational fluid dynamics. The company was founded by Charles A. Taylor, Nathan M. Wilson, and Christopher K. Zarins in July 2007 and is headquartered in Mountain View, CA.

PresidentMr. John C.M. Farquhar

Chief Financial OfficerMr. Vikram Verghese C.F.A.

M.D.Dr. Campbell D.K. Rogers FACC

Co-FounderDr. John Henry Stevens M.D.

Senior Vice President of OperationsMs. Kathleen Carey

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Farquhar John C.M.	Chief Executive Officer	Oct 12 '26	Sale	49.57	38,900	1,928,195	283,014	Oct 14 06:05 PM
Farquhar John C.M.	Officer	Oct 12 '26	Proposed Sale	49.57	38,900	1,928,195		Oct 13 08:21 AM
Rogers Campbell	Chief Medical Officer	Sep 18 '26	Option Exercise	7.94	13,179	104,588	99,638	Sep 21 06:19 PM
Rogers Campbell	Chief Medical Officer	Sep 18 '26	Sale	50.15	19,682	987,052	79,956	Sep 21 06:19 PM
Verghese Vikram	Chief Financial Officer	Sep 18 '26	Sale	50.75	16,766	850,926	155,183	Sep 18 08:46 PM
Verghese Vikram	Chief Financial Officer	Sep 17 '26	Sale	50.11	7,579	379,816	171,949	Sep 18 08:46 PM
Verghese Vikram	Officer	Sep 18 '26	Proposed Sale	50.75	16,766	850,927		Sep 18 04:22 PM
Rogers Campbell	Member of immediate family of	Sep 18 '26	Proposed Sale	50.15	5,653	283,498		Sep 18 10:12 AM
Rogers Campbell	Officer	Sep 18 '26	Proposed Sale	50.15	19,682	987,052		Sep 18 09:56 AM
Verghese Vikram	Officer	Sep 17 '26	Proposed Sale	50.11	7,579	379,815		Sep 17 04:37 PM
Verghese Vikram	Chief Financial Officer	Sep 11 '26	Sale	50.06	29,714	1,487,459	184,789	Sep 15 07:44 PM
Verghese Vikram	Chief Financial Officer	Sep 14 '26	Sale	50.24	4,593	230,744	180,196	Sep 15 07:44 PM
Verghese Vikram	Chief Financial Officer	Sep 15 '26	Sale	50.01	668	33,408	179,528	Sep 15 07:44 PM
Verghese Vikram	Officer	Sep 15 '26	Proposed Sale	50.01	668	33,408		Sep 15 04:40 PM
Farquhar John C.M.	Chief Executive Officer	Sep 10 '26	Sale	46.42	35,010	1,625,105	325,804	Sep 14 06:41 PM
Farquhar John C.M.	Chief Executive Officer	Sep 11 '26	Sale	50.00	3,890	194,500	321,914	Sep 14 06:41 PM
Verghese Vikram	Officer	Sep 14 '26	Proposed Sale	50.24	4,593	230,744		Sep 14 04:15 PM
Farquhar John C.M.	Officer	Sep 11 '26	Proposed Sale	50.00	3,890	194,500		Sep 11 04:52 PM
Verghese Vikram	Officer	Sep 11 '26	Proposed Sale	50.06	29,714	1,487,460		Sep 11 04:34 PM
Verghese Vikram	Chief Financial Officer	Sep 08 '26	Sale	50.03	6,640	332,212	214,503	Sep 10 05:24 PM
Farquhar John C.M.	Officer	Sep 10 '26	Proposed Sale	46.42	35,010	1,625,104		Sep 10 04:32 PM
Verghese Vikram	Officer	Sep 08 '26	Proposed Sale	50.03	6,640	332,212		Sep 08 04:11 PM
Verghese Vikram	Chief Financial Officer	Sep 03 '26	Sale	49.69	27,540	1,368,471	221,143	Sep 04 05:29 PM
Verghese Vikram	Chief Financial Officer	Sep 02 '26	Sale	50.60	5,876	297,326	248,683	Sep 04 05:29 PM
Verghese Vikram	Officer	Sep 03 '26	Proposed Sale	49.69	27,540	1,368,472		Sep 03 05:32 PM
Verghese Vikram	Officer	Sep 02 '26	Proposed Sale	50.60	5,876	297,326		Sep 02 11:23 AM
Farquhar John C.M.	Chief Executive Officer	Aug 21 '26	Sale	50.00	27,230	1,361,500	360,814	Aug 25 05:32 PM
Farquhar John C.M.	Officer	Aug 21 '26	Proposed Sale	50.00	27,230	1,361,500		Aug 21 01:07 PM
Farquhar John C.M.	Chief Executive Officer	Aug 18 '26	Sale	45.00	32,676	1,470,420	388,044	Aug 20 05:56 PM
Rogers Campbell	Chief Medical Officer	Aug 17 '26	Option Exercise	19.00	9,219	175,161	95,678	Aug 19 09:04 PM
Rogers Campbell	Chief Medical Officer	Aug 17 '26	Sale	41.23	9,219	380,099	86,459	Aug 19 09:04 PM
Farquhar John C.M.	Chief Executive Officer	Aug 14 '26	Sale	39.06	15,560	607,774	420,720	Aug 18 06:38 PM
Farquhar John C.M.	Officer	Aug 18 '26	Proposed Sale	45.00	32,676	1,470,420		Aug 18 05:11 PM
Rogers Campbell	Officer	Aug 17 '26	Proposed Sale	41.23	9,219	380,099		Aug 17 12:51 PM
Cohen Arthur Bruce	Affiliate of HCPCIV 1 LLC	Aug 14 '26	Proposed Sale	42.17	200,000	8,434,000		Aug 14 04:58 PM
Healey Joseph Patrick	Affiliate of HCPCIV 1 LLC	Aug 14 '26	Proposed Sale	41.50	150,000	6,225,000		Aug 14 03:29 PM
Farquhar John C.M.	Officer	Aug 14 '26	Proposed Sale	39.06	15,560	607,774		Aug 14 12:35 PM
Farquhar John C.M.	Chief Executive Officer	Aug 10 '26	Sale	28.31	22,562	638,730	436,280	Aug 12 05:07 PM
Farquhar John C.M.	Officer	Aug 10 '26	Proposed Sale	28.31	22,562	638,730		Aug 10 01:00 PM
Farquhar John C.M.	Chief Executive Officer	Jul 30 '26	Option Exercise	5.06	31,220	158,014	466,593	Jul 31 06:16 PM
Verghese Vikram	Chief Financial Officer	Jul 27 '26	Option Exercise	2.22	22,522	49,999	255,898	Jul 28 05:47 PM
Lightcap Jeffrey C	Director	Jul 24 '26	Option Exercise	19.00	47,420	900,980	293,681	Jul 28 05:42 PM
BARABE TIMOTHY C	Director	Jul 22 '26	Option Exercise	19.00	3,710	70,490	188,231	Jul 24 06:40 PM
Verghese Vikram	Chief Financial Officer	Jul 21 '26	Option Exercise	2.22	22,522	49,999	233,376	Jul 23 05:56 PM
BARABE TIMOTHY C	Director	Jul 17 '26	Option Exercise	19.00	5,000	95,000	184,521	Jul 20 06:18 PM
Rogers Campbell	Chief Medical Officer	Jul 15 '26	Option Exercise	19.00	9,219	175,161	97,950	Jul 17 05:54 PM
Rogers Campbell	Chief Medical Officer	Jul 15 '26	Sale	25.72	9,219	237,113	88,731	Jul 17 05:54 PM
Rogers Campbell	Officer	Jul 15 '26	Proposed Sale	25.72	9,219	237,113		Jul 15 10:05 AM
Farquhar John C.M.	Chief Executive Officer	Jul 10 '26	Sale	27.75	22,562	626,096	435,373	Jul 13 08:25 PM
WELDON WILLIAM C	Director	Jul 08 '26	Option Exercise	8.33	51,369	427,904	243,931	Jul 10 05:50 PM
Farquhar John C.M.	Officer	Jul 10 '26	Proposed Sale	27.75	22,562	626,096		Jul 10 09:43 AM
Farquhar John C.M.	Chief Executive Officer	Jun 24 '26	Sale	35.00	38,900	1,361,500	457,935	Jun 26 06:08 PM
Farquhar John C.M.	Officer	Jun 24 '26	Proposed Sale	35.00	38,900	1,361,500		Jun 24 10:38 AM
Rogers Campbell	Chief Medical Officer	Jun 15 '26	Option Exercise	2.22	10,000	22,200	88,731	Jun 17 05:39 PM
Farquhar John C.M.	Chief Executive Officer	Jun 10 '26	Sale	28.50	22,562	643,017	496,835	Jun 12 06:55 PM
Farquhar John C.M.	Officer	Jun 10 '26	Proposed Sale	28.50	22,562	643,017		Jun 10 10:47 AM
Rogers Campbell	Chief Medical Officer	May 18 '26	Option Exercise	19.00	9,219	175,161	87,950	May 20 05:55 PM
Rogers Campbell	Chief Medical Officer	May 18 '26	Sale	28.34	9,219	261,266	78,731	May 20 05:55 PM
Rogers Campbell	Officer	May 18 '26	Proposed Sale	28.34	9,219	261,266		May 18 11:48 AM
Farquhar John C.M.	Chief Executive Officer	May 11 '26	Sale	29.12	22,562	657,005	519,397	May 13 06:23 PM
Farquhar John C.M.	Officer	May 11 '26	Proposed Sale	29.12	22,562	657,005		May 11 10:20 AM
Bain Capital Life Sciences Inv	10% Owner	Apr 30 '26	Sale	29.23	948,757	27,733,644	8,448,158	Apr 30 08:46 PM
Bain Capital Life Sciences Inv	10% Owner	Apr 29 '26	Sale	29.37	797,133	23,411,796	9,396,915	Apr 30 08:46 PM
Bain Capital Life Sciences Inv	10% Owner	Apr 28 '26	Sale	30.51	254,110	7,752,896	10,194,048	Apr 30 08:46 PM
Farquhar John C.M.	Chief Executive Officer	Apr 10 '26	Sale	26.72	22,562	602,857	549,163	Apr 14 05:53 PM
Farquhar John C.M.	Officer	Apr 10 '26	Proposed Sale	26.72	22,562	602,857		Apr 10 11:03 AM
Rogers Campbell	Chief Medical Officer	Apr 01 '26	Option Exercise	2.25	67,017	150,556	145,535	Apr 03 06:15 PM
Rogers Campbell	Chief Medical Officer	Apr 01 '26	Sale	24.64	64,533	1,590,093	81,002	Apr 03 06:15 PM
Rogers Campbell	Officer	Apr 01 '26	Proposed Sale	24.64	64,533	1,589,935		Apr 01 04:23 PM
Rogers Campbell	Chief Medical Officer	Mar 19 '26	Option Exercise	2.22	67,017	148,778	143,051	Mar 23 06:33 PM
Rogers Campbell	Chief Medical Officer	Mar 19 '26	Sale	25.69	64,533	1,658,033	78,518	Mar 23 06:33 PM
Farquhar John C.M.	Chief Executive Officer	Mar 18 '26	Sale	25.00	9,725	243,125	571,725	Mar 20 06:24 PM
Rogers Campbell	Officer	Mar 19 '26	Proposed Sale	25.69	64,533	1,658,030		Mar 19 04:23 PM
Farquhar John C.M.	Officer	Mar 18 '26	Proposed Sale	25.00	9,725	243,125		Mar 18 02:17 PM
BARABE TIMOTHY C	Director	Mar 11 '26	Option Exercise	2.22	8,667	19,241	179,521	Mar 12 07:57 PM
Farquhar John C.M.	Chief Executive Officer	Mar 10 '26	Sale	22.66	12,837	290,886	581,450	Mar 12 07:55 PM
Farquhar John C.M.	Officer	Mar 10 '26	Proposed Sale	22.66	12,837	290,886		Mar 10 10:53 AM
Cullivan Julie A	Director	Mar 05 '26	Sale	25.00	9,122	228,050	27,291	Mar 06 08:18 PM
Cullivan Julie A	Director	Mar 05 '26	Proposed Sale	25.00	9,122	228,050		Mar 05 02:11 PM
BARABE TIMOTHY C	Director	Feb 17 '26	Option Exercise	8.33	2,497	20,800	170,854	Feb 19 07:14 PM
Rogers Campbell	Chief Medical Officer	Feb 12 '26	Option Exercise	5.84	67,016	391,398	141,187	Feb 17 08:07 PM
Rogers Campbell	Chief Medical Officer	Feb 12 '26	Sale	24.49	65,153	1,595,486	76,034	Feb 17 08:07 PM
Rogers Campbell	Officer	Feb 12 '26	Proposed Sale	24.49	65,153	1,595,485		Feb 12 04:45 PM
Farquhar John C.M.	Chief Executive Officer	Feb 10 '26	Sale	27.46	22,562	619,553	591,656	Feb 10 08:24 PM
Farquhar John C.M.	Officer	Feb 10 '26	Proposed Sale	27.46	22,562	619,557		Feb 10 04:12 PM
Cullivan Julie A	Director	Feb 05 '26	Sale	27.32	8,000	218,560	36,413	Feb 06 09:42 PM
Bain Capital Life Sciences Inv	10% Owner	Feb 04 '26	Sale	28.05	2,000,000	56,100,000	10,448,158	Feb 06 04:58 PM
Cullivan Julie A	Director	Feb 05 '26	Proposed Sale	27.32	8,000	218,560		Feb 05 09:58 AM
Lightcap Jeffrey C	Director	Dec 16 '25	Buy	26.34	40,000	1,053,680	40,000	Dec 17 06:43 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

HTFL

Heartflow Inc

Upgrade your Finviz experience